SARS-CoV-2 infection in autologous stem cell transplantation
Intern Med J
.
2021 Aug;51(8):1352-1353.
doi: 10.1111/imj.15255.
Authors
Kaitlyn Wiltshire
1
,
Anna Kalff
1
,
Catherine O Morrissey
2
,
David Griffin
3
,
Sushrut Patil
1
,
Stephanie Spring
3
,
Andrew Spencer
1
,
David Kliman
1
Affiliations
1
Department of Haematology, Alfred Health, Melbourne, Victoria, Australia.
2
Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Victoria, Australia.
3
Department of Infectious Diseases, Alfred Health, Melbourne, Victoria, Australia.
PMID:
34423537
PMCID:
PMC8653091
DOI:
10.1111/imj.15255
No abstract available
Publication types
Case Reports
Letter
MeSH terms
COVID-19*
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Male
Middle Aged
Transplantation, Autologous